» Articles » PMID: 11950672

Use of ICD-9 Coding for Estimating the Occurrence of Cerebrovascular Malformations

Overview
Specialty Neurology
Date 2002 Apr 16
PMID 11950672
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Accurate epidemiologic data concerning cerebrovascular malformations are scarce. Our goals were to determine the distribution of lesions in the International Classification of Diseases, Ninth Revision, (ICD-9) code for cerebrovascular malformations and to evaluate the use of state discharge registries for estimating their detection rate.

Methods: We reviewed records of all patients discharged from our center between January 1, 1992, and June 30, 1999, whose diagnoses included the ICD-9 code for cerebrovascular anomaly (code 747.81) to determine the accuracy of the coding. Hospital admission rates for cerebrovascular anomaly were calculated by using the 1995-1999 state discharge databases of California and New York.

Results: Of 804 patients with this code, 706 (88%) had a lesion consistent with the diagnosis. Five lesions accounted for 99% of the diagnoses; the two most common were AVM (66%) and cavernous malformation (13%). The ratio of AVMs to all cerebrovascular anomalies was similar to that in a prior population-based study. The sensitivity of identifying a patient with cerebrovascular malformation by using ICD-9 coding was 94%; the false-positive rate was 1.7 cases per 100,000 person-years. For California and New York, rates of first hospital admission for cerebrovascular malformation were 1.5 and 1.8 cases per 100,000 person-years, respectively.

Conclusion: Rates of admission for cerebrovascular malformations calculated from state discharge databases are consistent with disease detection rates in the range of 1 case per 100,000 person-years. However, the false-positive rate for coding is in the same range as the disease detection rate. Thus, current state discharge registries cannot serve as sources of detailed epidemiologic data.

Citing Articles

Risk factors associated with in-hospital complications for pediatric sickle-cell disease-associated moyamoya syndrome: a nationwide cross-sectional study.

Osorio R, Raygor K, Rinaldo L, Fox C, Bhasin N, Abla A Childs Nerv Syst. 2024; 40(7):2109-2114.

PMID: 38530413 DOI: 10.1007/s00381-024-06363-2.


Maternal Race/Ethnicity, Hypertension, and Risk for Stroke During Delivery Admission.

Miller E, Zambrano Espinoza M, Huang Y, Friedman A, Boehme A, Bello N J Am Heart Assoc. 2020; 9(3):e014775.

PMID: 31973601 PMC: 7033883. DOI: 10.1161/JAHA.119.014775.


Effect of A Randomized trial of Unruptured Brain Arteriovenous Malformation on Interventional Treatment Rates for Unruptured Arteriovenous Malformations.

Reynolds A, Chen M, Merkler A, Chatterjee A, Diaz I, Navi B Cerebrovasc Dis. 2019; 47(5-6):299-302.

PMID: 31434094 PMC: 6759368. DOI: 10.1159/000502314.


Disparities in epilepsy surgery in the United States of America.

Sanchez Fernandez I, Stephen C, Loddenkemper T J Neurol. 2017; 264(8):1735-1745.

PMID: 28702686 DOI: 10.1007/s00415-017-8560-6.


Use of EEG in critically ill children and neonates in the United States of America.

Gainza-Lein M, Sanchez Fernandez I, Loddenkemper T J Neurol. 2017; 264(6):1165-1173.

PMID: 28503704 DOI: 10.1007/s00415-017-8510-3.


References
1.
Jellinger K . Vascular malformations of the central nervous system: a morphological overview. Neurosurg Rev. 1986; 9(3):177-216. DOI: 10.1007/BF01743136. View

2.
Stapf C, Mohr J . New concepts in adult brain arteriovenous malformations. Curr Opin Neurol. 2000; 13(1):63-7. DOI: 10.1097/00019052-200002000-00012. View

3.
Brown Jr R, Wiebers D, Torner J, OFallon W . Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology. 1996; 46(4):949-52. DOI: 10.1212/wnl.46.4.949. View

4.
Chewning S, Nussman D, Griffo M, Kiebzak G . Health care information processing: how accurate are the data?. J South Orthop Assoc. 1997; 6(1):8-16. View

5.
Ogilvy C, Stieg P, Awad I, Brown Jr R, Kondziolka D, Rosenwasser R . AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001; 32(6):1458-71. DOI: 10.1161/01.str.32.6.1458. View